Atlas Trials

Value of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases

Clinical trial NCT04504526 · RECRUITING

Trial details

NCT number
NCT04504526
Sponsor
First Affiliated Hospital of Fujian Medical University
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
LymphomaMultiple MyelomaLeukemia
Start date
2020-08-07
Primary completion
2027-12-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.